- Home
- TWIN vs TVGN Comparison
TWIN vs TVGN Comparison
Compare TWIN & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TWIN | TVGN |
|---|---|---|
| Founded | 1918 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Blank Checks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 224.5M | 89.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TWIN | TVGN |
|---|---|---|
| Price | $15.74 | $0.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $5.00 |
| AVG Volume (30 Days) | 24.8K | ★ 1.4M |
| Earning Date | 02-04-2026 | 11-14-2025 |
| Dividend Yield | ★ 1.05% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $347,837,000.00 | N/A |
| Revenue This Year | $10.79 | N/A |
| Revenue Next Year | $8.43 | N/A |
| P/E Ratio | $826.62 | ★ N/A |
| Revenue Growth | ★ 14.24 | N/A |
| 52 Week Low | $6.16 | $0.38 |
| 52 Week High | $17.08 | $1.92 |
Technical Indicators
Market Signals| Indicator | TWIN | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 53.52 | 37.72 |
| Support Level | $15.28 | $0.39 |
| Resistance Level | $16.09 | $0.47 |
| Average True Range (ATR) | 0.58 | 0.04 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 69.06 | 8.19 |
Price Performance
Historical ComparisonAbout TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.